31255-26-2

Basic information

• Product Name: Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-
• Synonyms: Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-;1-broMo-2-(2-(2-(2-broMoethoxy)ethoxy) ethoxy)ethane;Bromo-PEG4-bromide;Br-PEG3-bromide;Br-PEG3-Br
• CAS NO: 31255-26-2
• Molecular Formula: C₈H₁₆Br₂O₃
• Molecular Weight: 320.01884
• Mol File: 31255-26-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 146 °C(Press: 0.06 Torr)
• Appearance: /
• Density: 1.5686 g/cm3
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-(31255-26-2)
• EPA Substance Registry System: Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-(31255-26-2)

Safety Data

• Hazardous Substances Data: 31255-26-2(Hazardous Substances Data)

Usage

Description

Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)is a chemical compound that features an ethane core with two bromoethoxy groups attached to it via an oxygen atom. The presence of bromine atoms makes it a good candidate for nucleophilic substitution reactions, while the ethoxy groups provide hydrophilicity and solubility in aqueous environments.

Uses

Used in Chemical Synthesis:
Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)is used as an intermediate in the synthesis of various organic compounds. The bromine atoms serve as reactive sites for further chemical reactions, allowing for the creation of a wide range of molecules with different functionalities.
Used in Pharmaceutical Industry:
Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)is used as a building block for the development of new pharmaceuticals. Its ability to participate in nucleophilic substitution reactions makes it a versatile component in the synthesis of complex drug molecules.
Used in Material Science:
Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)can be utilized in the development of new materials with specific properties. Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-'s hydrophilic nature and reactivity can be exploited to create materials with tailored characteristics for various applications, such as in coatings, adhesives, or polymers.
Used in Drug Delivery Systems:
Similar to gallotannin, Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)can be employed in drug delivery systems to improve the solubility, bioavailability, and therapeutic outcomes of certain drugs. Ethane,1,1'-Oxybis〔2-(2-bromoethoxy)-'s reactivity and hydrophilicity make it a suitable candidate for the development of novel drug carriers and delivery platforms.

Upstream product

• 123-91-1 1,4-dioxane 
• 112-60-7 Tetraethylene glycol 
• 603-35-0 triphenylphosphine 

Downstream Products

• 60147-30-0 10,13,16-tris(p-tolylsulphonyl)-1,4,7-trioxa-10,13,16-triazacyclo-octadecane 
• 60147-32-2 10,14,18-tris(p-tolylsulphonyl)-1,4,7-trioxa-10,14,18-triazacycloicosane 
• 130759-58-9 1,13-bis-1,4,7,10,13-pentaoxatridecane 
• 75953-70-7 N,N'-dibenzyl-1,11-diamino-3,6,9-trioxaundecane dihydrochloride 
• 120808-63-1 10,14,17,21-tetrakis(p-tolylsulphonyl)-1,4,7-trioxa-10,14,17,21-tetra-azacyclotricosane 
• 87338-14-5 1,13-bis(p-tolylsulfonyl)-1,13-diaza-4,7,10-trioxacyclooctadecane 
• 74461-34-0 10,16-bis(p-tolylsulphonyl)-1,4,7,13-tetraoxa-10,16-diazacyclo-octadecane 
• 120808-60-8 10,19-bis-(p-tolylsulphonyl)-1,4,7,13,16-pentaoxa-10,19-diazacyclohemicosane 
• 101210-59-7 10,22-bis(p-tolylsulphonyl)-1,4,7,13,16,19-hexaoxa-10,22-diazcyclotetracosane 
• 87338-15-6 1,13-bis(p-tolylsulfonyl)-1,13-diaza-4,7,10-trioxacyclotricosane 
• 98572-17-9 N-(p-tolylsulphonyl)-1,4,7-trioxa-10-azacyclododecane 
• 80392-32-1 [2-(2-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-benzene 
• 20768-77-8 1,13-diphenyl-1,4,7,10,13-pentaoxatridecane 
• 136755-48-1 6,7,9,10,12,13,15,16-Octahydro-8,11,14-trioxa-5,17-diselena-benzocyclopentadecene 

Relevant articles and documents

Mono- and dicationic short PEG and methylene dioxyalkylglycerols for use in synthetic gene delivery systems

A range of monocationic and dicationic dioxyalkylglycerol cytofectins have been synthesised possessing methylene and short n-ethylene glycol spacers. The monocationic compounds were found to be effective in transfections when formulated as lipopolyplexes with peptide and DNA components, in particular with shorter PEG head groups which may have less effect on peptide targeting in the ternary complex. The Royal Society of Chemistry 2008.